Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.4 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.4 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |